Published in Antimicrob Agents Chemother on November 01, 1981
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Cell-wall-defective variants of Fusobacterium. Antimicrob Agents Chemother (1989) 1.73
Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques. Antimicrob Agents Chemother (1985) 1.63
Survey of anaerobic susceptibility patterns in Canada. Antimicrob Agents Chemother (1986) 1.60
Differences in susceptibilities of species of the Bacteroides fragilis group to several beta-lactam antibiotics: indole production as an indicator of resistance. Antimicrob Agents Chemother (1982) 1.52
Comparative in vitro activity of ceftriaxone against anaerobic bacteria. Antimicrob Agents Chemother (1982) 1.37
Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics. Antimicrob Agents Chemother (1984) 1.35
In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections. Antimicrob Agents Chemother (1982) 1.30
Two fatal cases of Veillonella bacteremia. Eur J Clin Microbiol Infect Dis (1998) 1.22
Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group. Antimicrob Agents Chemother (1984) 1.18
Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin. Antimicrob Agents Chemother (1983) 1.17
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics. J Clin Microbiol (1986) 1.15
Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology. Antimicrob Agents Chemother (1990) 1.10
Comparison of cefoperazone and cefoxitin concentrations in serum and pelvic tissue of abdominal hysterectomy patients. Antimicrob Agents Chemother (1982) 1.10
Clinical evaluation of moxalactam. Antimicrob Agents Chemother (1982) 0.98
Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections. Antimicrob Agents Chemother (1985) 0.96
Cefmenoxime therapy of serious bacterial infections. Antimicrob Agents Chemother (1984) 0.94
Occurrence of clindamycin-resistant anaerobic bacteria isolated from cultures taken following clindamycin therapy. Antimicrob Agents Chemother (1986) 0.89
Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria. Antimicrob Agents Chemother (1986) 0.88
Non-vertebral Veillonella species septicemia and osteomyelitis in a patient with diabetes: a case report and review of the literature. J Med Case Rep (2014) 0.85
In vitro activity of cefbuperazone against Bacteroides spp. Antimicrob Agents Chemother (1985) 0.85
In vitro susceptibility of Clostridium difficile to new beta-lactam and quinolone antibiotics. Antimicrob Agents Chemother (1985) 0.85
In vitro antibacterial effects of cephalosporins. Drugs (1987) 0.84
In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria. Antimicrob Agents Chemother (1985) 0.81
Susceptibilities of Bacteroides and Fusobacterium spp. from foot rot in goats to 10 beta-lactam antibiotics. Antimicrob Agents Chemother (1990) 0.80
Ceftizoxime: a third-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society. CMAJ (1990) 0.79
Cephalosporins in surgery. Prophylaxis and therapy. Drugs (1987) 0.76
Role of cephalosporins in the era of Clostridium difficile infection. J Antimicrob Chemother (2016) 0.76
In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone. Antimicrob Agents Chemother (1982) 0.75
Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals. Antimicrob Agents Chemother (1985) 0.75
HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1979) 10.60
Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother (1976) 9.53
Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrob Agents Chemother (1975) 8.86
In vitro activity of thienamycin. Antimicrob Agents Chemother (1978) 8.76
beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin. Antimicrob Agents Chemother (1978) 8.28
In vitro activity of LY127935. Antimicrob Agents Chemother (1979) 7.01
Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods. J Antimicrob Chemother (1978) 5.23
Characterisation of a -lactamase obtained from a strain of Bacteroides fragilis resistant to -lactam antibiotics. J Med Microbiol (1973) 4.58
Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. J Infect Dis (1975) 4.16
Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic. Antimicrob Agents Chemother (1977) 4.14
In vitro activity of LY127935. Antimicrob Agents Chemother (1979) 3.88
Metronidazole versus anaerobes. In vitro data and initial clinical observations. Calif Med (1972) 3.62
Bacteroides fragilis resistant to the administration of clindamycin. Am J Med (1976) 3.13
Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins. Antimicrob Agents Chemother (1980) 2.76
Beta-lactamase activity in anaerobic bacteria. Antimicrob Agents Chemother (1976) 2.75
Inactivation of cephalosporins by Bacteroides. Antimicrob Agents Chemother (1979) 2.75
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother (1980) 2.47
Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species. Rev Infect Dis (1981) 2.38
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.23
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin. Antimicrob Agents Chemother (1980) 2.20
BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins. J Antibiot (Tokyo) (1977) 2.00
Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis. J Antimicrob Chemother (1980) 1.95
Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics. Antimicrob Agents Chemother (1980) 1.92
Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics. Antimicrob Agents Chemother (1978) 1.78
Variability in the susceptibility pattern of Bacteroides fragilis in four Detroit area hospitals. Antimicrob Agents Chemother (1979) 1.62
Beta-Lactamase activity in strains of Bacteroides melaninogenicus and Bacteroides oralis. Antimicrob Agents Chemother (1977) 1.62
Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria. Antimicrob Agents Chemother (1980) 1.59
Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens. Antimicrob Agents Chemother (1975) 1.43
Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538. Antimicrob Agents Chemother (1978) 1.32
In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria. Rev Infect Dis (1989) 0.92
Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo). J Antimicrob Chemother (1980) 0.89
In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone. Chemotherapy (1981) 0.81
Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol (1979) 12.54
Rapid diagnosis of bacteremia. Appl Microbiol (1969) 11.82
Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother (1976) 9.53
Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli. Appl Microbiol (1971) 6.99
Standardized antimicrobial disc susceptibility testing of anaerobic bacteria. I. Susceptibility of Bacteroides fragilis to tetracycline. Appl Microbiol (1972) 6.17
Bacteremia after genitourinary tract manipulation: bacteriological aspects and evaluation of various blood culture systems. Appl Microbiol (1972) 6.04
Aetiology of antimicrobial-agent-associated colitis. Lancet (1978) 5.91
Antibiotic susceptibility patterns as aids in classification and characterization of gram-negative anaerobic bacilli. J Bacteriol (1967) 5.67
Rapid diagnosis of bacteremia with quantitative differential-membrane filtration culture. JAMA (1966) 5.66
Practical aerobic membrane filtration blood culture technique: clinical blood culture trial. J Clin Microbiol (1975) 4.80
Bactericidal activity of five antimicrobial agents against Bacteroides fragilis. J Infect Dis (1972) 4.62
Effect of diet on human fecal flora: comparison of Japanese and American diets. Am J Clin Nutr (1974) 4.58
Legionnaires' disease: clinical features of 24 cases. Ann Intern Med (1978) 4.30
Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. J Infect Dis (1975) 4.16
Laboratory diagnosis of Legionnaires' disease. Am Rev Respir Dis (1980) 3.95
Use of a semiselective medium to culture Legionella pneumophila from contaminated lung specimens. J Clin Microbiol (1979) 3.86
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
Evaluation of polyanethol sulfonate (liquoid) in blood cultures. Antimicrob Agents Chemother (Bethesda) (1967) 3.80
Comparison of three procedures for biochemical testing of anaerobic bacteria. J Clin Microbiol (1975) 3.75
Management of anaerobic infections. Ann Intern Med (1975) 3.62
Metronidazole versus anaerobes. In vitro data and initial clinical observations. Calif Med (1972) 3.62
Susceptibility of Bacteroides fragilis to six antibiotics determined by standardized antimicrobial disc susceptibility testing. Antimicrob Agents Chemother (1973) 3.47
Comparison of methods for isolation of anaerobic bacteria from clinical specimens. Appl Microbiol (1973) 3.30
Anaerobic pleuropulmonary infections. Medicine (Baltimore) (1972) 3.30
Lincomycin: activity against anaerobes and effect on normal human fecal flora. Antimicrob Agents Chemother (Bethesda) (1965) 3.29
Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med (1972) 3.05
Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature. Medicine (Baltimore) (1980) 2.81
Immunologic diagnosis of Legionnaires' disease: cross-reactions with anaerobic and microaerophilic organisms and infections caused by them. J Infect Dis (1980) 2.76
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71
Purification and characterization of Clostridium difficile toxin. Infect Immun (1979) 2.71
Bacteriology of human and animal bite wounds. J Clin Microbiol (1978) 2.66
Effect of a partially chemically defined diet on normal human fecal flora. Am J Clin Nutr (1972) 2.62
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. J Clin Microbiol (1982) 2.52
Comparison of selective media for isolation of presumptive group D streptococci from human feces. Appl Microbiol (1971) 2.52
Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol (2000) 2.50
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother (1985) 2.47
Anaerobic infections of the lung and pleural space. Am Rev Respir Dis (1974) 2.46
Legionnaires' disease: unusual clinical and laboratory features. Ann Intern Med (1980) 2.46
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother (1988) 2.45
Combined screw-cap and rubber-stopper closure for Hungate tubes (pre-reduced anaerobically sterilized roll tubes and liquid media). Appl Microbiol (1969) 2.44
Standardized antimicrobial disc susceptibility testing of anaerobic bacteria: in vitro susceptibility of Clostridium perfringens to nine antibiotics. Antimicrob Agents Chemother (1972) 2.42
Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species. Rev Infect Dis (1981) 2.38
Gram-negative anaerobic bacilli: Their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera. Rev Infect Dis (1981) 2.27
Cephalothin in serious bacterial infection. Ann Intern Med (1966) 2.25
Antimicrobial resistance in Bacteroides. J Antimicrob Chemother (1987) 2.23
Rapid method that aids in distinguishing Gram-positive from Gram-negative anaerobic bacteria. J Clin Microbiol (1981) 2.22
Antibacterial sensitivity of Bifidobacterium (Lactobacillus bifidus). J Bacteriol (1967) 2.21
Isolation of a new serotype of legionnaires' disease bacterium. Lancet (1978) 2.21
Treatment of anaerobic infections with metronidazole. Antimicrob Agents Chemother (1975) 2.21
Practical aerobic membrane filtration blood culture technique: development of procedure. J Clin Microbiol (1975) 2.20
Therapy for infections due to anaerobic bacteria: an overview. J Infect Dis (1977) 2.14
Rosamicin: in vitro activity against anaerobes and comparison with erythromycin. Antimicrob Agents Chemother (1976) 2.12
Joint infection by anaerobic bacteria: a case report and review of the literature. Arthritis Rheum (1969) 2.09
Uncommonly encountered, motile, anaerobic gram-negative bacilli associated with infection. Rev Infect Dis (1988) 2.09
Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect Immun (1987) 2.06
The bacteriology of gangrenous and perforated appendicitis--revisited. Ann Surg (1990) 2.05
A microbiological comparison between acute and complicated appendicitis. Clin Infect Dis (1992) 2.02
Bacteriology of empyema. Lancet (1974) 2.00
Bilophila wadsworthia, gen. nov. and sp. nov., a unique gram-negative anaerobic rod recovered from appendicitis specimens and human faeces. J Gen Microbiol (1989) 1.98
Isolation of Legionella pneumophila from blood. Lancet (1979) 1.97
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother (2007) 1.95
Infections due to anaerobes. Med Times (1968) 1.86
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae. Gastroenterology (1980) 1.84
A miniature anaerobic jar for tissue transport or for cultivation of anaerobes. Am J Clin Pathol (1970) 1.79
In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria. Antimicrob Agents Chemother (1985) 1.77
Diarrhea and colitis associated with antimicrobial therapy in man and animals. Am J Clin Nutr (1979) 1.76
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria. Antimicrob Agents Chemother (1996) 1.76
Legionnaires' disease in renal-transplant recipients. Lancet (1978) 1.75
Isolation of Legionella pneumophila from a transtracheal aspirate. J Clin Microbiol (1979) 1.74
A simple, rapid method to process and assay fatty acids and alcohols by gas chromatography. Anal Biochem (1973) 1.74
Bacterial interference between Clostridium difficile and normal fecal flora. J Infect Dis (1981) 1.73
Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin. Antimicrob Agents Chemother (1981) 1.73
Haemophilus aphrophilus infections: clinical and bacteriologic studies. Ann N Y Acad Sci (1970) 1.73
Cell-wall-defective variants of Fusobacterium. Antimicrob Agents Chemother (1989) 1.73
Bone infections involving anaerobic bacteria. Medicine (Baltimore) (1978) 1.71
Clinical aspects of bacteremia after manipulation of the genitourinary tract. J Infect Dis (1973) 1.70
Practical aspects of anaerobic sepsis. Medicine (Baltimore) (1973) 1.70
Amikacin therapy for serious gram-negative bacillary infections. Ann Intern Med (1975) 1.70
Role of anaerobic bacteria in bite-wound infections. Rev Infect Dis (1984) 1.66
Fecal microbial flora in Seventh Day Adventist populations and control subjects. Am J Clin Nutr (1977) 1.65
Intestinal bacteria. The role they play in normal physiology, pathologic physiology, and infection. Calif Med (1969) 1.64
Bacteroides gracilis, an important anaerobic bacterial pathogen. J Clin Microbiol (1985) 1.60
Antimicrobial agent-induced diarrhea--a bacterial disease. J Infect Dis (1977) 1.59
Anaerobic pyogenic liver abscess. Ann Intern Med (1972) 1.59
Cefoxitin: clinical evaluation in thirty-eight patients. Antimicrob Agents Chemother (1977) 1.58
Potable water as a source of Legionnaires' disease. JAMA (1985) 1.56
Polyacrylamide gel electrophoresis patterns produced by Clostridium difficile. Rev Infect Dis (1984) 1.56
Sutterella wadsworthensis gen. nov., sp. nov., bile-resistant microaerophilic Campylobacter gracilis-like clinical isolates. Int J Syst Bacteriol (1996) 1.55
Fecal bacteriology of colonic polyp patients and control patients. Cancer Res (1975) 1.54
The effect of antimicrobial agents on human faecal flora: studies with cephalexin, cyclacillin and clindamycin. Soc Appl Bacteriol Symp Ser (1974) 1.50
Intestinal beta-lactamase activity in ampicillin-induced, Clostridium difficile-associated ileocecitis. J Infect Dis (1983) 1.49
Measurement of lactic acid in cerebrospinal fluid of patients with infections of the central nervous system. J Infect Dis (1978) 1.48
Endocarditis due to anaerobic gram-negative bacilli. Am J Med (1973) 1.48